|
|
Mylan N.V.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
generic version accepted: $20.54Mylan Labs subsidiary launches generic version of Viramune tablets (MYL) 20.71 -0.56 : Co announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the FDA for its Abbreviated New Drug Application for Nevirapine Tablets USP, 200 mg. This product is the generic version of Boehringer Ingelheim's Viramune and is indicated for combination antiretroviral (ARV) treatment of HIV-1 infection. |
|
|
return to message board, top of board |
